We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

FDA Approval Of Whole Grain Health Claim For Type 2 Diabetes Is Hardly A Ringing Endorsement

September 24, 2013: 12:00 AM EST
The FDA has approved a petition from U.S. food makers for a qualified health claim linking whole grain food consumption with a reduced risk for type 2 diabetes, despite an analysis of scientific studies that revealed “very limited credible evidence” of such a link. Nevertheless, one of the petitioners, ConAgra Foods Inc., said it was “thrilled” by the FDA decision, noting that the agency “is confirming that whole grains … can help reduce the risk of developing type 2 diabetes.” Actually, the decision means that foods containing whole grains may carry the following claim: “Whole grains may reduce the risk of type 2 diabetes, although the FDA has concluded that there is very limited scientific evidence for this claim.”
"ConAgra Foods – Maker of 100% Whole Grain Orville Redenbacher's Popcorn and Ultragrain Whole Wheat Flour – Applauds FDA Approval of Qualified Health Claim", News release, ConAgra Foods, September 24, 2013, © ConAgra Foods, Inc
Food & Nutrition
Whole Grains
North America
United States of America
Companies, Organizations
Legal, Legislation, Regulation, Policy
Press Release
Research, Studies, Advice
Developed by Yuri Ingultsov Software Lab.